Yiqin Zuo

Medicine & Life Sciences

1. Kidney 100%
2. Podocytes 70%
3. Atherosclerosis 49%
4. Wounds and Injuries 45%
5. Cyclooxygenase 2 Inhibitors 44%
6. Losartan 41%
7. Angiotensin II 40%
8. Chronic Renal Insufficiency 37%
9. Apolipoproteins E 34%
10. Angiotensin II Type 1 Receptor Blockers 33%
11. Macrophages 32%
12. rofecoxib 32%
13. Pioglitazone 31%
14. Puromycin Aminonucleoside 30%
15. Angiotensins 28%
16. Proteinuria 27%
17. Meloxicam 26%
18. Fibrosis 26%
19. Angiotensin Type 1 Receptor 24%
20. Indomethacin 22%
21. AST 120 22%
22. AIDS-Associated Nephropathy 21%
23. HIV-1 21%
24. goralatide 21%
25. Thymosin 20%
26. nef Genes 20%
27. Elastin 19%
28. Peroxisome Proliferator-Activated Receptors 19%
29. vpr Genes 18%
30. Angiotensin Type 2 Receptor 18%
31. Sclerosis 17%
32. Cyclooxygenase 2 16%
33. Acceleration 16%
34. Foam Cells 15%
35. Charcoal 15%
36. Angiotensin Receptors 15%
37. Blood Pressure 15%
38. ATP-Binding Cassette Transporters 14%
39. Transforming Growth Factor beta 14%
40. Kidney Diseases 14%
41. Atherosclerotic Plaques 14%
42. Nephrectomy 14%
43. Nephrotic Syndrome 14%
44. PPAR gamma 13%
45. Hydralazine 13%
46. Joint Diseases 13%
47. Ureteral Obstruction 13%
48. Transforming Growth Factors 13%
49. Streptozocin 12%